249 related articles for article (PubMed ID: 14592683)
1. Mecamylamine acutely increases human intravenous nicotine self-administration.
Rose JE; Behm FM; Westman EC; Bates JE
Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
Rose JE; Behm FM; Westman EC
Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
[TBL] [Abstract][Full Text] [Related]
3. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
Harris AC; Manbeck KE; Schmidt CE; Shelley D
Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
[TBL] [Abstract][Full Text] [Related]
4. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
[TBL] [Abstract][Full Text] [Related]
5. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
[TBL] [Abstract][Full Text] [Related]
6. Blockade of nicotine self-administration with nicotinic antagonists in rats.
Watkins SS; Epping-Jordan MP; Koob GF; Markou A
Pharmacol Biochem Behav; 1999 Apr; 62(4):743-51. PubMed ID: 10208381
[TBL] [Abstract][Full Text] [Related]
7. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.
Ponzoni L; Moretti M; Sala M; Fasoli F; Mucchietto V; Lucini V; Cannazza G; Gallesi G; Castellana CN; Clementi F; Zoli M; Gotti C; Braida D
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1775-86. PubMed ID: 26141510
[TBL] [Abstract][Full Text] [Related]
8. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
Stoker AK; Olivier B; Markou A
Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
[TBL] [Abstract][Full Text] [Related]
9. Reboxetine: attenuation of intravenous nicotine self-administration in rats.
Rauhut AS; Mullins SN; Dwoskin LP; Bardo MT
J Pharmacol Exp Ther; 2002 Nov; 303(2):664-72. PubMed ID: 12388649
[TBL] [Abstract][Full Text] [Related]
10. Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.
Lundahl LH; Henningfield JE; Lukas SE
Pharmacol Biochem Behav; 2000 Jul; 66(3):637-43. PubMed ID: 10899382
[TBL] [Abstract][Full Text] [Related]
11. Mecamylamine does not precipitate withdrawal in cigarette smokers.
Eissenberg T; Griffiths RR; Stitzer ML
Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
[TBL] [Abstract][Full Text] [Related]
13. Effects of central and peripheral nicotinic blockade on human nicotine discrimination.
Perkins KA; Sanders M; Fonte C; Wilson AS; White W; Stiller R; McNamara D
Psychopharmacology (Berl); 1999 Feb; 142(2):158-64. PubMed ID: 10102768
[TBL] [Abstract][Full Text] [Related]
14. Mecamylamine increases nicotine preference and attenuates nicotine discrimination.
Rose JE; Sampson A; Levin ED; Henningfield JE
Pharmacol Biochem Behav; 1989 Apr; 32(4):933-8. PubMed ID: 2798542
[TBL] [Abstract][Full Text] [Related]
15. Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.
Madsen HB; Koghar HS; Pooters T; Massalas JS; Drago J; Lawrence AJ
Addict Biol; 2015 May; 20(3):500-12. PubMed ID: 24750355
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and sensorimotor components of satiation in cigarette smoking.
Rose JE; Behm FM; Westman EC; Bates JE; Salley A
Pharmacol Biochem Behav; 2003 Sep; 76(2):243-50. PubMed ID: 14592675
[TBL] [Abstract][Full Text] [Related]
17. Nicotine-mecamylamine interactions.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
[TBL] [Abstract][Full Text] [Related]
18. 'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration.
O'Dell LE; Koob GF
Pharmacol Biochem Behav; 2007 Feb; 86(2):346-53. PubMed ID: 17292952
[TBL] [Abstract][Full Text] [Related]
19. Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats.
Liu X; Palmatier MI; Caggiula AR; Donny EC; Sved AF
Psychopharmacology (Berl); 2007 Nov; 194(4):463-73. PubMed ID: 17616849
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus.
Sorge RE; Pierre VJ; Clarke PB
Psychopharmacology (Berl); 2009 Dec; 207(2):191-200. PubMed ID: 19756529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
